News-Medical.Net on MSN
LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations
LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), ...
The agentic operating system for life sciences R&DPRESS RELEASESigmatic Sciences, a Sapio Sciences company, enables scientists to move ...
In this interview, we speak to Mostafa ElSayed, CEO of Automata, about their new, open, integrated lab automation platform Automata LINQ and how it unlocks labs' people, space and potential. Please ...
Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.
As AI and automation reshape drug discovery, laboratories themselves are being forced to evolve. Gensler’s Ryley Poblete joins the podcast to explain how new technologies, the makeup of scientific ...
How has technology changed the way we conduct research? Lab automation takes many different forms with the purpose of streamlining several aspects of experiments, data collection and data analysis.
Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...
The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...
Lab workflows are constantly evolving to handle higher throughput demands, increased efficiency, and more complex tasks. For some, that means allowing automation to play a bigger role in the lab.
Labroots is delighted to host the 11th Annual Event in the Laboratory Automation Virtual Event Series, scheduled on March 17th, 2027! Dive into the cutting edge of laboratory technology at this free ...
LONDON, January 29, 2026--(BUSINESS WIRE)--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results